GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, GPR35, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MET, NR1H4, PPARA, PTGS2, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2, XDH |
12.6581 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, EGFR, F10, F3, FLT3, GPR35, HMGCR, HSPA1A, INSR, KDR, MET, MMP12, MMP9, NR1H4, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
12.6581 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, EGFR, F10, F3, FLT3, GPR35, HMGCR, HSPA1A, INSR, KDR, MET, MMP12, MMP9, NR1H4, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
12.6581 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, GPR35, HMGCR, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2, XDH |
12.1519 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MMP2, NR1H4, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR |
12.1051 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2, TYR, XDH |
11.8057 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AXL, BCL2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, ESRRA, FABP3, HMGCR, HSD11B2, HSD17B2, IDO1, IGF1R, INSR, MMP2, MMP9, NR1H4, PPARA, PTGS2, RORC, SRC, TEK, TYR |
11.3434 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GPR35, HMGCR, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2, XDH |
10.7981 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, EGFR, ESR1, ESRRA, F3, FABP3, FLT3, HMGCR, HSPA1A, IDO1, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGS2, SMAD3, SRC, TEK, XDH |
10.4684 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, F10, F3, FLT3, GPR35, HMGCR, HSPA1A, INSR, KDR, MET, MMP12, MMP9, NR1H4, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
10.4684 |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MMP2, MMP9, NR1H4, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR |
10.2973 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, ESR1, FABP3, FABP4, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, NR1H4, PPARA, PTGS2 |
10.2973 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NR1H4 |
10.2973 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD1, DUSP3, EGFR, ESR1, ESRRB, F10, F3, FABP4, HMGCR, HSD11B2, HSD17B2, IDO1, IGF1R, INSR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS2, TYR |
10.2636 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR1H4, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, THRA, TNKS, TNKS2, XDH |
9.89273 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR1H4, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, THRA, TNKS, TNKS2, XDH |
9.73069 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESRRA, F10, F3, FABP4, FLT3, GPR35, HMGCR, HSPA1A, IDO1, INSR, KDR, MET, MMP12, MMP2, MMP9, NR1H4, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
9.73026 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, IDO1, NR1H4, PTGS2, RORC, SRC, TYR |
9.52349 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, F10, F3, FLT3, GPR35, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR1H4, NUAK1, PTGS2, PTPN1, SRC, TEK, XDH |
9.52195 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, GPR35, HMGCR, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP12, MMP2, MMP9, NR1H4, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, THRA, TNKS, TNKS2, XDH |
9.40581 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2, TYR, XDH |
9.04197 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP2, NR1H4, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2, TYR, XDH |
9.00389 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AXL, BCL2, CYP1B1, EGFR, F10, F3, FLT3, GPR35, HMGCR, HSPA1A, INSR, KDR, MET, PTGS2, PTPN1, SRC, TEK, XDH |
8.93546 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, ALPL, BCL2, CA2, CSNK2A1, CYP1A2, DRD1, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, IGF1R, INSR, MMP2, NR1H4, PPARA, PTGS2, SMAD3, SRC, TEK |
8.88564 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA6, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, FABP3, FUT7, GBA2, HMGCR, HSPA1A, IDO1, NR1H4, PIM1, PPARA, PTGS2, TYR, XDH |
8.6308 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2, XDH |
8.4117 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HMGCR, HSPA1A, IDO1, IGF1R, KDR, MET, MMP9, NR1H4, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, THRA, XDH |
8.34204 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, AXL, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, EGFR, F10, F3, GPR35, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, THRA |
8.34204 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HMGCR, HSPA1A, IDO1, IGF1R, KDR, MET, MMP9, NR1H4, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
8.32932 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HMGCR, HSPA1A, IDO1, IGF1R, KDR, MET, MMP9, NR1H4, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, THRA, XDH |
8.32336 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, EGFR, ESR1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NR1H4 |
8.26633 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2, TYR, XDH |
8.21139 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HMGCR, HSPA1A, IDO1, IGF1R, KDR, MET, MMP9, NR1H4, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK |
8.21139 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, AURKB, BCL2, CDC25B, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2, XDH |
8.00788 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2, XDH |
7.9493 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR1H4, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, THRA, TNKS, TNKS2, XDH |
7.84861 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALOX15, ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR1H4, PTGS2, RORC, SMAD3, SRC |
7.8086 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, HMGCR, HSPA1A, IDO1, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2, XDH |
7.78365 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
7.77626 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, BCL2, CA2, CA7, CDK6, DRD1, EGFR, HMGCR, KDR, NR1H4, PTGS2, SRC, TNKS, TNKS2 |
7.76269 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2, XDH |
7.75277 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HMGCR, HSPA1A, IDO1, IGF1R, KDR, MMP9, NR1H4, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, THRA, XDH |
7.72701 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, ALPL, BCL2, CA2, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, INSR, PPARA, PTGS2, SRC, TEK |
7.59494 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HMGCR, HSPA1A, IDO1, IGF1R, KDR, MMP9, NR1H4, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK |
7.5409 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PIM1, PPARA, RORC, SRC, THRA, THRB |
7.48371 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, INSR, KDR, PPARA, SMAD3, SRC, TEK, THRA, TYR |
7.48371 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, RORC, SRC, THRA, THRB |
7.48096 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, BCL2, CYP19A1, CYP1B1, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
7.42573 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, ALPL, AURKB, AXL, BCL2, CA2, CA6, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NR1H4, NUAK1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, TYR |
7.33006 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, ESR1, F3, FLT3, HMGCR, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, PIM1, PTGS2, TEK |
7.32817 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, DRD1, EGFR, ESRRB, FABP3, FLT3, HMGCR, INSR, KDR, MMP9, NR1H4, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.326 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, DRD1, EGFR, ESRRB, FABP3, FLT3, HMGCR, INSR, KDR, MMP9, NR1H4, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.326 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALOX15, ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, NR1H4, PTGS2, RORC, SMAD3, SRC |
7.326 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, CDK6, CYP19A1, DUSP3, EGFR, ESR1, F3, FABP4, HMGCR, HSPA1A, IDO1, IGF1R, MET, MMP12, MMP2, NR1H4, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.31227 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
7.31144 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
7.31144 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
7.31144 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
7.30347 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PTGS2, TYR, XDH |
7.29255 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, DRD1, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, MMP9, NR1H4, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.26569 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AURKB, AXL, BCL2, CA2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD17B2, INSR, KDR, MET, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS2, TYR |
7.25136 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, ALOX15, BCL2, CDK6, CYP19A1, DRD1, DUSP3, EGFR, ESR1, ESR2, HMGCR, HSPA1A, IGF1R, MET, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.2126 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, DRD1, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, MMP9, NR1H4, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.205 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
7.14469 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DAO, DRD1, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, GBA2, HMGCR, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
7.09108 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, ESRRA, FLT3, HSD11B2, PTGS2, RORC, SRC, TEK, TYR |
7.0802 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, HMGCR, HSPA1A, IDO1, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2, XDH |
7.00315 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
7.00157 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
7.00157 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, ADRA2C, BCL2, DRD1, DUSP3, EGFR, ESR1, ESR2, GPR35, HMGCR, HSPA1A, IGF1R, MET, MMP12, MMP9, NR1H4, PTGS2, PTPN1, SMAD3, SRC, XDH |
6.97451 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, ADRA2C, BCL2, DRD1, DUSP3, EGFR, ESR1, ESR2, GPR35, HMGCR, HSPA1A, IGF1R, MET, MMP12, MMP9, NR1H4, PTGS2, PTPN1, SMAD3, SRC, XDH |
6.95329 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, INSR, KDR, MMP9, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, THRA, TYR |
6.92045 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.81746 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DAO, DRD1, GBA2, HMGCR, NR1H4, TYR |
6.7539 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, RORC, SRC, THRA, THRB |
6.60418 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.58088 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, FABP3, FLT3, HMGCR, NR1H4, PPARA, PTGS2, RORC, SRC, TEK, THRA |
6.44136 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, BCL2, CA2, CDK6, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, F3, GPR35, HMGCR, HSPA1A, IDO1, INSR, KDR, MET, MMP12, MMP9, NR1H4, PIM1, PTGS2, SMAD3, SRC, TEK, THRA, THRB, TNKS2, XDH |
6.35871 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, PTPN1, SRC, TEK, TNKS, XDH |
6.22666 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, PTGS2, SRC |
6.18703 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.05887 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
5.97973 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA6, CA7 |
5.94821 |
[BP] GO:0022414 |
reproductive process
|
ADRA2C, AKR1B1, ALPL, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, DRD1, EGFR, ESR1, ESRRB, HSD11B2, HSD17B2, IDO1, INSR, MMP2, MMP9, PTGS2, SRC, THRA, THRB |
5.85505 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD1, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, HMGCR, HSPA1A, IGF1R, INSR, MET, MMP9, NR1H4, NUAK1, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
5.85505 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGS2, PTPN1, SRC, TEK, TNKS, XDH |
5.84532 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, EGFR, ESR1, F3, FABP4, HMGCR, IDO1, KDR, MET, MMP12, NR1H4, PPARA, PTGS2, SMAD3, TEK |
5.81688 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD1, EGFR, HMGCR, HSD11B2, HSPA1A, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, THRA, TYR |
5.80419 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, DRD1, DUSP3, EGFR, ESRRB, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, MMP9, PPARA, PTGS2, PTPN1, SRC, TEK, XDH |
5.77451 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, EGFR, HMGCR, PTGS2, SRC, TEK |
5.71832 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
5.7105 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, RORC, THRA, THRB |
5.60925 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, EGFR, MMP2, MMP9, TEK, THRA |
5.536 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, AURKB, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, HMGCR, IGF1R, MET, MMP9, NR1H4, PIM1, PPARA, PTGS2, PTPN1, SRC, TNKS |
5.53114 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TNKS |
5.50453 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
5.48503 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, ADRA2C, ALOX15, AXL, BCL2, CA2, CA7, CYP19A1, DRD1, EGFR, GPR35, HMGCR, HSPA1A, INSR, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, SMAD3, SRC, THRA |
5.43937 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALOX15, ALPL, AURKB, AXL, BCL2, CA2, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR1H4, NUAK1, PTGS2, PTPN1, RORC, SMAD3, SRC |
5.43937 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FABP3, FABP4, FUT7, GBA2, HMGCR, MET, PPARA, PTGS2 |
5.33031 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.22647 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, EGFR, ESRRB, FLT3, HMGCR, INSR, KDR, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
5.17838 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.09856 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, DRD1, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
5.08851 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.04856 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, HSPA1A, IDO1, MMP12, MMP2, NR1H4, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
5.04126 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, ADRA2C, AXL, BCL2, CA2, CYP1B1, EGFR, ESRRB, F3, HMGCR, HSPA1A, IDO1, KDR, MET, MMP12, MMP9, NR1H4, PIM1, PTGS2, SMAD3, SRC, TEK |
5.00099 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
4.96414 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, FABP3, FABP4, FUT7, GBA2, HSPA1A, IDO1, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.94258 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, ADRA2C, ALOX15, EGFR, FLT3, HMGCR, INSR, KDR, PTPN1, SRC, TEK, XDH |
4.86154 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
4.84999 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DUSP3, ESR1, HMGCR, HSPA1A, IGF1R, MET, MMP9, NR1H4, PTGS2, PTPN1, SRC, XDH |
4.809 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, ADRA2C, ALOX15, DUSP3, EGFR, FLT3, HMGCR, IGF1R, INSR, KDR, PTPN1, SRC, TEK, XDH |
4.78714 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, RORC, THRA, THRB |
4.78629 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, EGFR, HMGCR, PTGS2, SRC, TEK |
4.78629 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, EGFR, FLT3, HMGCR, INSR, KDR, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
4.74871 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DRD1, EGFR, HSPA1A, IDO1 |
4.72133 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, F10, F3, INSR, MET, SRC, TEK, XDH |
4.68825 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F10, F3, INSR, MET, SRC, TEK |
4.67505 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, F3, FLT3, HMGCR, HSPA1A, INSR, KDR, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.63478 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, DRD1, DUSP3, EGFR, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTGS2, PTPN1, SRC, TEK, XDH |
4.60792 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, AXL, BCL2, CA12, CA2, CA7, DRD1, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, INSR, MET, NR1H4, SMAD3, SRC |
4.55373 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CDK6, CYP1B1, DRD1, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, NR1H4, PTGS2, RORC, SRC |
4.54345 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
4.54345 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PTGS2 |
4.51341 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, AURKB, BCL2, CSNK2A1, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, THRA, THRB, TNKS, TNKS2, XDH |
4.50815 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD1, EGFR, FABP3, FLT3, HSD11B2, IGF1R, INSR, MMP2, NR1H4, PPARA, PTGS2, SRC, TEK, TYR |
4.50579 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.50062 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, NR1H4, SRC, TEK, TNKS |
4.47444 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, EGFR, NR1H4, PTGS2, TNKS, TNKS2 |
4.4722 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AURKB, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, KDR, MET, MMP12, NR1H4, PPARA, PTGS2, RORC, SMAD3, SRC, THRA, THRB, TNKS, TNKS2 |
4.4722 |
[BP] GO:0050793 |
regulation of developmental process
|
ADRA2C, AXL, BCL2, CA2, CDK6, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, F3, HMGCR, IDO1, INSR, KDR, NR1H4, NUAK1, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, THRA, TNKS2, XDH |
4.43599 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, EGFR, ESR1, F3, FLT3, HMGCR, HSPA1A, INSR, KDR, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.42196 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FLT3, FUT7, GBA2, HMGCR, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2, TYR, XDH |
4.38191 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AXL, BCL2, CA1, CA2, CDK6, CSNK2A1, CYP1B1, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, NR1H4, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2 |
4.37862 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, IDO1, NR1H4, PPARA, PTGS2, SMAD3, TEK |
4.3693 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TNKS |
4.30453 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A2, CYP1B1, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR1H4, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2, XDH |
4.23965 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
AURKB, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, IGF1R, INSR, MET, MMP12, NR1H4, PPARA, PTPN1, RORC, SMAD3, SRC, THRA, THRB, TNKS, TNKS2 |
4.23277 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, EGFR, PPARA, SMAD3 |
4.1929 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HMGCR, MMP2, MMP9, PTGS2 |
4.17884 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK |
4.17884 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, NR1H4, PPARA, PTGS2, SRC, TEK |
4.17515 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, EGFR, HMGCR, PTGS2 |
4.15615 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, EGFR, HMGCR, PTGS2 |
4.15615 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, BCL2, DUSP3, EGFR, ESR1, ESR2, HMGCR, HSPA1A, IGF1R, MET, MMP12, MMP9, NR1H4, PTGS2, PTPN1, SMAD3, SRC, XDH |
4.15584 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, HMGCR |
4.13731 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD1, EGFR, FABP3, FLT3, HSD11B2, IGF1R, INSR, MMP2, NR1H4, PPARA, PTGS2, SRC, TEK, TYR |
4.13638 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, BCL2, CA12, CA2, CA7, DRD1, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, MET, NR1H4, SMAD3 |
4.10142 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR1H4, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2, XDH |
4.07997 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, NR1H4, SRC, TEK |
4.07997 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, BCL2, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
4.05606 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
AURKB, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, MET, MMP12, NR1H4, PPARA, PTGS2, RORC, SMAD3, SRC, THRA, THRB, TNKS, TNKS2 |
4.02162 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, DUSP3, EGFR, FLT3, HMGCR, IGF1R, INSR, PTPN1, SRC |
4.00767 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, EGFR, HMGCR, PTGS2 |
3.99825 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, EGFR, HMGCR, PTGS2 |
3.98067 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CDK6, CYP1A1, CYP1B1, DRD1, EGFR, FABP3, HMGCR, HSD11B2, KDR, PTGS2, SRC |
3.97507 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.90356 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, GBA2 |
3.90227 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FLT3, PTGS2, RORC, SRC |
3.89831 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, AXL, BCL2, CDC25B, CDK6, CYP1A1, DRD1, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, HMGCR, KDR, MET, MMP2, MMP9, PTGS2, RORC, SMAD3, SRC, TEK, THRA, THRB |
3.85399 |
[BP] GO:0051094 |
positive regulation of developmental process
|
ADRA2C, AXL, BCL2, CA2, CYP1B1, ESRRB, F3, HMGCR, IDO1, INSR, KDR, NR1H4, PIM1, PTGS2, SMAD3, SRC, TEK, THRA |
3.80007 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, AURKB, BCL2, CSNK2A1, DUSP3, ESR1, ESR2, ESRRA, FABP4, HMGCR, HSPA1A, IGF1R, MET, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, THRA, THRB, TNKS, TNKS2, XDH |
3.80007 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR1H4, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2, XDH |
3.78391 |
[BP] GO:0051172 |
None
|
ADRA2A, AURKB, CSNK2A1, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HMGCR, HSPA1A, IGF1R, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, THRA, THRB, TNKS, TNKS2, XDH |
3.77097 |
[BP] GO:0032845 |
None
|
ADORA1, ADRA2A, BCL2, HMGCR, SRC, TNKS, TNKS2 |
3.77069 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CDK6, CYP1B1, DRD1, EGFR, KDR, PTGS2, SRC |
3.7636 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRA2A, ADRA2C, AURKB, CDC25B, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, PTPN1, SRC, TEK, TNKS |
3.73601 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR1H4, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2, XDH |
3.70542 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
3.70542 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.70378 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTGS2, PTPN1, SRC |
3.68453 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
3.67294 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.64712 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
3.64328 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
3.64268 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, FLT3, HSD11B2, PTGS2, SRC |
3.62987 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, AURKB, AXL, BCL2, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.62408 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, DRD1, EGFR, ESR1, FLT3, IGF1R, INSR, MMP2, NR1H4, PTGS2, SMAD3, SRC |
3.62408 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA2A, ADRA2C, AURKB, BCL2, CDC25B, EGFR, ESR1, ESR2, F3, FLT3, HSPA1A, INSR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
3.62408 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR1H4, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2, XDH |
3.62408 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2, PTGS2, SRC |
3.60017 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, IDO1, NR1H4, PPARA, PTGS2 |
3.59662 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.5487 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADRA2A, ADRA2C, CA2, EGFR, HMGCR, MMP12, NR1H4, PTGS2, PTPN1, SMAD3, SRC, THRA |
3.53725 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, CDK6, KDR, SMAD3, SRC, TEK |
3.5138 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
3.49124 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX15, CYP19A1, CYP3A4, DAO, HMGCR, TYR |
3.48621 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, EGFR, FLT3, HMGCR, INSR, KDR, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
3.47226 |
[BP] GO:0051051 |
negative regulation of transport
|
ADORA1, ADRA2A, ADRA2C, BCL2, GPR35, HMGCR, HSPA1A, MMP9, NR1H4, PTGS2, THRA |
3.47226 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, PTGS2, SRC |
3.47226 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD1, HMGCR, KDR, SRC |
3.45568 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
3.43793 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.41807 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.40194 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, BCL2, CA2, CYP19A1, DRD1, EGFR, INSR, MMP12, NR1H4, PTGS2, SMAD3, SRC |
3.40003 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, IGF1R, INSR, KDR, MET, MMP12, NR1H4, PPARA, RORC, SMAD3, SRC, THRA, THRB, TNKS, TNKS2 |
3.39613 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, INSR, PTGS2, SMAD3, XDH |
3.39216 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, NR1H4, PTGS2, SRC |
3.3761 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, THRA, TYR |
3.37033 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, MMP12, NR1H4, PPARA, SMAD3, TEK |
3.36897 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADRA2A, ADRA2C, CDC25B, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, PTPN1, SRC, TEK |
3.36169 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.35573 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, FABP3, NR1H4, PPARA |
3.33433 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
3.3261 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, BCL2, CA1, CSNK2A1, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, NR1H4, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.3179 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, DAO, FABP3, GBA2, IDO1, NR1H4, PIM1, PPARA, PTGS2, TYR |
3.31374 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, NR1H4, PPARA, SMAD3, TEK |
3.29135 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
AURKB, CSNK2A1, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HMGCR, HSPA1A, IGF1R, KDR, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, THRA, THRB, TNKS, TNKS2, XDH |
3.28406 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.24071 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, EGFR, HMGCR, HSD11B2, PTGS2, SRC, TYR |
3.22225 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HMGCR, IDO1 |
3.20006 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA2A, ADRA2C, AURKB, BCL2, CDC25B, EGFR, ESR1, F3, FLT3, HSPA1A, INSR, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
3.19984 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, PTGS2, SRC |
3.18708 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, DRD1, EGFR, PTGS2 |
3.17885 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.17254 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.16626 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, EGFR, ESR1, FLT3, MET, PIM1, SRC, TEK, TYR |
3.14721 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, HSD11B2, IGF1R, INSR, PPARA, PTGS2, SRC, TEK |
3.1396 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, BCL2, CDK6, KDR, SMAD3, SRC, TEK |
3.13707 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
ADRA2C, AXL, BCL2, CA2, CDK6, CYP1B1, EGFR, ESR1, ESRRA, F3, HMGCR, IDO1, INSR, KDR, NR1H4, PIM1, PTGS2, SMAD3, SRC, TEK, XDH |
3.13145 |
[BP] GO:0032148 |
None
|
ADRA2A, ADRA2C, INSR, SRC |
3.13141 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, NR1H4, SRC, TEK |
3.13141 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
AURKB, BCL2, CDC25B, CDK6, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TNKS |
3.12349 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
3.11519 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, BCL2, CDK6, CYP1B1, DUSP3, IDO1, KDR, NUAK1, PPARA, SMAD3, SRC, TEK |
3.06112 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HMGCR, MMP2, MMP9, PTGS2 |
3.06068 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
3.06068 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, ADRA2C, CDC25B, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, PTPN1, SRC |
3.04981 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, ADRA2A, BCL2, CSNK2A1, EGFR, ESRRB, HSPA1A, INSR, KDR, MET, PPARA, PTPN1, SMAD3, THRA |
3.04461 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, DUSP3, EGFR, HMGCR, KDR, PTPN1, SRC, TEK |
3.03385 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GPR35, HMGCR, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2, TYR, XDH |
3.03385 |
[BP] GO:0045741 |
None
|
ADORA1, ADRA2A, ADRA2C |
3.02268 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
3.0181 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, NR1H4, PTGS2, SRC |
3.0082 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GPR35, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2, XDH |
3.00693 |
[BP] GO:0045742 |
None
|
ADORA1, ADRA2A, ADRA2C, MMP9 |
3.00693 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, HMGCR, NR1H4, PPARA, SMAD3, TEK |
2.99154 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, F3, FABP4, IDO1, KDR, MET, PTGS2, SMAD3 |
2.99154 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DAO, DRD1, TYR |
2.98955 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, ADRA2A, ADRA2C, AURKB, CDC25B, EGFR, FLT3, INSR, PTPN1, SRC, TEK, TNKS |
2.9844 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, HSD11B2, HSPA1A, IDO1, MMP2, MMP9, NR1H4, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, THRA |
2.96712 |
[BP] GO:0008050 |
None
|
THRA, THRB |
2.95799 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.95799 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, EGFR, ESR1, PPARA, RORC, SRC |
2.94748 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA2A, ADRA2C, EGFR, PTGS2, THRA, THRB |
2.93791 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.93487 |
[BP] GO:1901186 |
None
|
ADORA1, ADRA2A, ADRA2C, MMP9 |
2.93307 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.9286 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, KDR, SRC |
2.90542 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, DAO, FABP3, GBA2, IDO1, NR1H4, PIM1, PPARA, PTGS2, TYR |
2.90542 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, PTGS2, TYR |
2.90491 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2, PTGS2 |
2.90058 |
[BP] GO:0070201 |
None
|
ACHE, ADRA2A, ADRA2C, BCL2, EGFR, HMGCR, MMP12, NR1H4, PTGS2, PTPN1, SMAD3, SRC, THRA |
2.89453 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, ADRA2A, BCL2, GPR35, MMP9, PTGS2 |
2.86814 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.85928 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.85928 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, AXL, BCL2, CA2, CDK6, CYP19A1, DUSP3, ESR1, ESRRA, HSPA1A, IDO1, MMP12, MMP2, NR1H4, PTPN1, SMAD3, SRC |
2.85086 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 |
2.85086 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.85086 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS2 |
2.84335 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, NR1H4, PTGS2, SRC |
2.84335 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, DAO, FABP3, GBA2, IDO1, NR1H4, PIM1, PPARA, PTGS2, TYR |
2.8363 |
[BP] GO:0051704 |
multi-organism process
|
ADRA2C, AXL, BCL2, CDK6, CYP1A1, EGFR, HSD11B2, HSPA1A, IDO1, INSR, KDR, MET, MMP1, MMP12, NR1H4, SMAD3, SRC |
2.83297 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, BCL2, CYP1B1, DRD1, EGFR, HMGCR, HSD11B2, INSR, PTGS2, SRC, TEK, THRA, THRB, TYR |
2.83029 |
[BP] GO:0042058 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, MMP9 |
2.82337 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, DRD1, EGFR, IGF1R, INSR, MMP2, NR1H4, PTGS2, SRC |
2.79218 |
[BP] GO:0061098 |
None
|
ADORA1, ADRA2A, ADRA2C, PTPN1 |
2.79218 |
[BP] GO:0009605 |
response to external stimulus
|
ADORA1, ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1A2, EGFR, HMGCR, HSD11B2, IDO1, MMP12, NR1H4, PTGS2, SMAD3, SRC, TYR |
2.78106 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, FABP3, FABP4, FUT7, GBA2, HSPA1A, IDO1, XDH |
2.76982 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, DUSP3, EGFR, FLT3, HMGCR, IGF1R, INSR, PTPN1, SRC |
2.75585 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, PTGS2, SMAD3, XDH |
2.7395 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, MMP1, MMP2, NR1H4, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.7352 |
[BP] GO:0001954 |
positive regulation of cell-matrix adhesion
|
CDK6, KDR, SMAD3, TEK |
2.72341 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CYP1A1, EGFR, HMGCR, HSD11B2, PTGS2, SRC, TYR |
2.71952 |
[BP] GO:0006464 |
cellular protein modification process
|
ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, NR1H4, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.70214 |
[BP] GO:0036211 |
protein modification process
|
ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, NR1H4, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.70214 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.69647 |
[BP] GO:0045986 |
None
|
ADORA1, ADRA2C, PTGS2 |
2.69647 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX15, ALOX5, PTGS2 |
2.69647 |
[BP] GO:0045934 |
None
|
ADRA2A, AURKB, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR1H4, PPARA, RORC, SMAD3, SRC, THRA, THRB, TNKS, TNKS2 |
2.68191 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
2.67567 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, FLT3, PTPN1, SRC |
2.66013 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA2A, ADRA2C, EGFR, GPR35, PTGS2, SMAD3, THRA, THRB |
2.65709 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTGS2, PTPN1, SRC |
2.63396 |
[BP] GO:0031349 |
positive regulation of defense response
|
EGFR, FABP4, HSPA1A, IDO1, MMP12, MMP2, NR1H4, PTGS2, SRC |
2.62775 |
[BP] GO:0010906 |
None
|
ESRRB, INSR, PPARA, RORC, SRC |
2.62466 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.62466 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.60969 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
2.58331 |
[BP] GO:0051726 |
regulation of cell cycle
|
AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, PTGS2, SMAD3, SRC, TNKS |
2.58331 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADRA2A, ADRA2C, BCL2, CSNK2A1, EGFR, HMGCR, MMP12, NR1H4, PTGS2, PTPN1, SMAD3, SRC, THRA |
2.58123 |
[BP] GO:1901184 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, MMP9 |
2.57129 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
CDK6, DUSP3, EGFR, HMGCR, HSPA1A, IGF1R, MET, NUAK1, PTGS2, PTPN1, XDH |
2.56813 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, DRD1, EGFR, IGF1R, INSR, MMP2, NR1H4, PTGS2, SRC |
2.56813 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.56813 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.56813 |
[BP] GO:0006808 |
regulation of nitrogen utilization
|
BCL2, NR1H4 |
2.56813 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.56813 |
[BP] GO:0050678 |
None
|
CDK6, EGFR, F3, KDR, MMP12, SMAD3, TEK, XDH |
2.56813 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
2.56345 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.5474 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.5474 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.5474 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.5474 |
[BP] GO:0007610 |
None
|
BCL2, DRD1, EGFR, HMGCR, IDO1, INSR, PPARA, PTGS2, THRA, THRB |
2.54695 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.52921 |
[BP] GO:0051254 |
None
|
EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MET, MMP12, NR1H4, PPARA, RORC, SMAD3, SRC, THRA, THRB, TNKS |
2.5275 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.52655 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.52655 |
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, PPARA, THRA |
2.52655 |
[BP] GO:0051223 |
None
|
ACHE, ADRA2A, ADRA2C, EGFR, HMGCR, MMP12, NR1H4, PTGS2, PTPN1, SMAD3, SRC, THRA |
2.52434 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, FABP3, NR1H4, PPARA |
2.52144 |
[BP] GO:0000122 |
None
|
AURKB, ESR1, ESR2, ESRRA, HSPA1A, MMP12, NR1H4, PPARA, RORC, SMAD3, THRA, THRB |
2.51596 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.51346 |
[BP] GO:0007617 |
None
|
DRD1, THRA, THRB |
2.51346 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP3A4, HMGCR, IDO1, PTGS2 |
2.50714 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, ADRA2A, ADRA2C, CDC25B, EGFR, FLT3, INSR, PTPN1, SRC, TEK |
2.50714 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.50281 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, AXL, CYP1A1, DRD1, EGFR, ESR1, PTGS2, SRC, THRA, THRB |
2.49615 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD1, EGFR, ESR1, FABP3, GPR35, NR1H4, SMAD3 |
2.47962 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, BCL2, MET, MMP9, PPARA, SMAD3, SRC, TNKS |
2.47624 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.47624 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.47624 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, AURKB, AXL, BCL2, CSNK2A1, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PTPN1, SMAD3, SRC, TEK, THRA, TNKS, TNKS2 |
2.47247 |
[BP] GO:0010811 |
positive regulation of cell-substrate adhesion
|
ALOX15, CDK6, KDR, SMAD3, TEK |
2.47074 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, ADRA2C, FLT3, PTPN1, SRC |
2.47029 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, EGFR, INSR, PTGS2, SMAD3 |
2.45158 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.43749 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, ADRA2A, ADRA2C, EGFR, HMGCR, MMP12, NR1H4, SRC |
2.42596 |
[BP] GO:1901361 |
None
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP3A4, DAO, HSPA1A, IDO1, XDH |
2.41283 |
[BP] GO:0043207 |
response to external biotic stimulus
|
ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1A2, IDO1, MMP12, NR1H4, PTGS2, SMAD3, SRC |
2.41283 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.40146 |
[BP] GO:0051968 |
None
|
DRD1, EGFR, PTGS2 |
2.40146 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.40146 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.3998 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.3998 |
[BP] GO:0071396 |
cellular response to lipid
|
AXL, CDK6, EGFR, ESR1, FLT3, NR1H4, RORC, SRC |
2.38205 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, ADRA2A, BCL2, EGFR, MET, PPARA, SMAD3 |
2.38029 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, ADRA2A, ADRA2C, CYP19A1, EGFR, HMGCR, NR1H4 |
2.38029 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, FABP3, FABP4, GBA2, HSPA1A, IDO1, SRC, XDH |
2.37288 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, ADRA2A, EGFR, FLT3, INSR, PTPN1, SRC |
2.37209 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DAO, DRD1 |
2.36765 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.35138 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TNKS, TNKS2 |
2.35138 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, EGFR, PTGS2 |
2.35138 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, RORC |
2.34602 |
[BP] GO:0001775 |
cell activation
|
ADRA2A, ADRA2C, ALOX5, AXL, BCL2, EGFR, FLT3, FUT7, HSPA1A, MMP9, RORC, SMAD3, SRC |
2.33981 |
[BP] GO:0035625 |
None
|
ADRA2A, ADRA2C |
2.33601 |
[BP] GO:0032811 |
None
|
ADRA2A, ADRA2C |
2.33601 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.33601 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.33601 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.33601 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.33601 |
[BP] GO:0019229 |
None
|
ADRA2A, ADRA2C, EGFR, PTGS2 |
2.33601 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, BCL2, CDK6, CYP1B1, FABP3, HSPA1A, IDO1, PTGS2, SMAD3, XDH |
2.33315 |
[BP] GO:0048608 |
reproductive structure development
|
AXL, BCL2, CYP19A1, ESR1, HSD17B2, INSR, SRC |
2.33267 |
[BP] GO:0050890 |
None
|
ADORA1, DRD1, EGFR, HMGCR, INSR, PTGS2, THRA |
2.31569 |
[BP] GO:0051953 |
None
|
ADORA1, ADRA2A, ADRA2C |
2.31349 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.31349 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA2A, ADRA2C, ALOX15, DRD1, EGFR, HMGCR, PTGS2 |
2.30665 |
[BP] GO:0045893 |
None
|
EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, NR1H4, PPARA, RORC, SMAD3, SRC, THRA, THRB, TNKS |
2.29995 |
[BP] GO:1903508 |
None
|
EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, NR1H4, PPARA, RORC, SMAD3, SRC, THRA, THRB, TNKS |
2.29995 |
[BP] GO:1902680 |
None
|
EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, NR1H4, PPARA, RORC, SMAD3, SRC, THRA, THRB, TNKS |
2.29733 |
[BP] GO:0009607 |
response to biotic stimulus
|
ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1A2, IDO1, MMP12, NR1H4, PTGS2, SMAD3, SRC |
2.28347 |
[BP] GO:0046888 |
None
|
ADORA1, ADRA2A, ADRA2C, HMGCR |
2.27074 |
[BP] GO:0043434 |
None
|
FABP3, HSD11B2, INSR, PPARA, PTGS2, SRC, TEK |
2.26949 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.2694 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.2694 |
[BP] GO:0007584 |
response to nutrient
|
ALPL, CYP1A1, EGFR, HMGCR, PTGS2, TYR |
2.26655 |
[BP] GO:0010675 |
None
|
ESRRB, INSR, PPARA, RORC, SRC |
2.25848 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, PTGS2 |
2.25072 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.25072 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ALOX15, ESR1, HSPA1A, KDR, MET, MMP1, SMAD3, SRC, TEK |
2.24322 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, EGFR, ESR1, MET, SMAD3, SRC |
2.23867 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.23011 |
[BP] GO:0006940 |
None
|
ADORA1, ADRA2A, ADRA2C, PTGS2 |
2.23011 |
[BP] GO:0051926 |
negative regulation of calcium ion transport
|
ADRA2A, BCL2, GPR35, PTGS2 |
2.23011 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, EGFR, HMGCR, KDR, SRC, TEK |
2.22743 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.22743 |
[BP] GO:0045932 |
None
|
ADORA1, ADRA2C, PTGS2 |
2.22743 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, PTGS2 |
2.21971 |
[BP] GO:0009416 |
response to light stimulus
|
AURKB, BCL2, DRD1, EGFR, HMGCR, PTGS2, TYR |
2.21868 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CYP1B1, F3, HMGCR, IDO1, MMP9, PTGS2, SMAD3, SRC, XDH |
2.21677 |
[BP] GO:0045892 |
None
|
AURKB, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR1H4, PPARA, RORC, SMAD3, SRC, THRA, THRB |
2.21482 |
[BP] GO:1900076 |
regulation of cellular response to insulin stimulus
|
ESRRA, NR1H4, PTPN1, SRC |
2.18626 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CYP1B1, F3, HMGCR, IDO1, MMP9, PTGS2, SMAD3, SRC, XDH |
2.18477 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.18465 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.18465 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.18465 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.18465 |
[BP] GO:0045913 |
None
|
ESRRB, INSR, PPARA, SRC |
2.16884 |
[BP] GO:0001817 |
regulation of cytokine production
|
ADRA2A, AXL, CYP1B1, HSPA1A, IDO1, MMP12, NR1H4, PTGS2, SMAD3, SRC |
2.16884 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.16884 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.16884 |
[BP] GO:0035624 |
None
|
ADRA2A, ADRA2C |
2.16884 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.16884 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.16884 |
[BP] GO:0060509 |
None
|
THRA, THRB |
2.16884 |
[BP] GO:0014060 |
None
|
ADRA2A, ADRA2C |
2.16884 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.15583 |
[BP] GO:0001819 |
positive regulation of cytokine production
|
ADRA2A, CYP1B1, HSPA1A, IDO1, MMP12, PTGS2, SMAD3, SRC |
2.14911 |
[BP] GO:1900078 |
None
|
ESRRA, NR1H4, SRC |
2.14911 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.14911 |
[BP] GO:0060341 |
regulation of cellular localization
|
ADRA2A, BCL2, CSNK2A1, DRD1, EGFR, HMGCR, NR1H4, PTGS2, PTPN1, SMAD3, SRC, THRA |
2.13872 |
[BP] GO:0030154 |
cell differentiation
|
ALPL, AXL, BCL2, CDK6, CYP1A1, ESR1, FABP4, FLT3, FUT7, HMGCR, KDR, MMP2, MMP9, PTGS2, RORC, SMAD3, THRA, THRB |
2.10804 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.10727 |
[BP] GO:0009411 |
response to UV
|
AURKB, BCL2, EGFR, PTGS2, TYR |
2.10677 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, DRD1, EGFR, PTGS2 |
2.10312 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, DRD1, EGFR, PTGS2 |
2.10312 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, ADRA2A, ADRA2C, CDC25B, EGFR, FLT3, INSR, PTPN1, SRC |
2.10152 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTGS2, PTPN1, SRC |
2.10095 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, ALOX15, AXL, CDK6, CYP19A1, DUSP3, IDO1, MMP12 |
2.08002 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.07289 |
[BP] GO:0043412 |
macromolecule modification
|
ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, NR1H4, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.07189 |
[BP] GO:0033280 |
response to vitamin D
|
ALPL, PTGS2, TYR |
2.07189 |
[BP] GO:0019098 |
None
|
DRD1, THRA, THRB |
2.07189 |
[BP] GO:0007176 |
None
|
ADORA1, ADRA2A, ADRA2C |
2.07189 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, EGFR, FLT3 |
2.07189 |
[BP] GO:1903507 |
None
|
AURKB, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR1H4, PPARA, RORC, SMAD3, SRC, THRA, THRB |
2.07029 |
[BP] GO:0035239 |
tube morphogenesis
|
BCL2, EGFR, ESR1, MET, SMAD3, SRC |
2.06705 |
[BP] GO:0010632 |
regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
2.06705 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
DUSP3, EGFR, HMGCR, IGF1R, PTPN1, XDH |
2.06705 |
[BP] GO:1902679 |
None
|
AURKB, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR1H4, PPARA, RORC, SMAD3, SRC, THRA, THRB |
2.06611 |
[BP] GO:0061097 |
None
|
ADORA1, ADRA2A, ADRA2C, PTPN1 |
2.06025 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
DUSP3, EGFR, HMGCR, IGF1R, PTPN1, XDH |
2.05868 |
[BP] GO:0010628 |
positive regulation of gene expression
|
DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MET, MMP12, NR1H4, PPARA, RORC, SMAD3, SRC, THRA, THRB, TNKS |
2.04423 |
[BP] GO:0031214 |
biomineral tissue development
|
ALOX15, ALPL, PPARA, PTGS2 |
2.04025 |
[BP] GO:0032868 |
None
|
FABP3, HSD11B2, INSR, PPARA, SRC |
2.03948 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.03948 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, HMGCR |
2.03948 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.03948 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.03948 |
[BP] GO:0045924 |
None
|
THRA, THRB |
2.03468 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.03468 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.03468 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.03468 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX15, ALOX5 |
2.03468 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.03468 |
[BP] GO:0051952 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1 |
2.03203 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.03203 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, ADRA2A, ADRA2C, EGFR, INSR, PTPN1, SRC |
2.02212 |
[BP] GO:0043433 |
negative regulation of DNA binding transcription factor activity
|
ADORA3, CYP1B1, ESR1, NR1H4, PIM1 |
2.02212 |
[BP] GO:0042060 |
None
|
ALOX15, EGFR, PPARA, SMAD3 |
2.01257 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.01114 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
CYP1A2, EGFR, MMP9 |
2.01114 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, EGFR, F10, FLT3, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, PTGS2, PTPN1 |
3.15745 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, EGFR, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, PTGS2 |
3.02789 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, ADRA2C, AKR1B1, AKR1B10, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA2, CA4, CA6, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, THRA, THRB, TNKS, TNKS2, TYR, XDH |
2.76556 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRA2C, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, AURKB, BCL2, CA1, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DRD1, DUSP3, EGFR, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, INSR, KDR, MMP2, MMP9, PIM1, PTGS2, PTPN1, SMAD3, SRC, THRA, TNKS, TNKS2, TYR, XDH |
2.58453 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.45853 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DRD1, EGFR, ESR1, F10, F3, FLT3, FUT7, GBA2, GPR35, HMGCR, HSD11B1, HSD11B2, HSD17B2, IGF1R, INSR, KDR, MET, MMP2, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR |
2.35672 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, ADRA2A, CA2, CA4, EGFR, TEK |
2.33408 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, CA4, DRD1, F10, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK |
2.14786 |
[CC] GO:0043226 |
organelle
|
ACHE, ADORA1, ADRA2C, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA2, CA4, CA6, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSPA1A, IDO1, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, THRA, THRB, TNKS, TNKS2, TYR, XDH |
2.13214 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.03468 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA6, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, PPARA, PTPN1, RORC, SMAD3, THRA, THRB, TNKS, TYR, XDH |
16.7652 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2, TYR, XDH |
13.3826 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DUSP3, EGFR, F10, F3, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGS2, PTPN1, SRC, TEK, TNKS, TNKS2, TYR, XDH |
12.0842 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
10.0785 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, RORC, THRA, THRB |
9.6244 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, RORC, THRA, THRB |
9.6244 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA6, CA7, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NR1H4, PPARA, PTPN1, RORC, SMAD3, THRA, THRB, TNKS |
9.52349 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, RORC, THRA, THRB |
8.9669 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PTGS2, TYR, XDH |
8.58438 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, ESR1, ESR2, ESRRA, ESRRB, F10, IDO1, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, THRA, THRB, TNKS, TNKS2, TYR, XDH |
7.72701 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, NR1H4, RORC |
7.68733 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.39042 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, NR1H4, PPARA, RORC, TEK, THRA, THRB |
7.14659 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, IDO1, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, THRA, THRB, TNKS, TNKS2, TYR, XDH |
6.94082 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.69742 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, CDK6, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, NR1H4, PPARA, RORC, TEK, THRA, THRB |
6.62057 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
6.35653 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, NR1H4, PPARA, RORC, TEK, THRA, THRB |
6.18945 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
6.16468 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, NR1H4, PPARA, RORC, SMAD3, TEK, THRA, THRB |
6.07263 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, HMGCR, HSD11B2, HSD17B1, IDO1, PTGS2, SRC, XDH |
5.96239 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD11B2, HSD17B1, NR1H4, PPARA, RORC |
5.86059 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
5.60925 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
5.49117 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.33255 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.18493 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, THRA |
5.18493 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, IDO1, PTGS2, SRC |
5.18321 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR, THRA, THRB |
5.14752 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.07937 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SMAD3, SRC, THRA |
5.00099 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, IDO1, PTGS2, SRC |
4.96414 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SRC, TEK |
4.78714 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.51081 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.25783 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ADRA2A, ADRA2C, AOX1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DRD1, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HMGCR, HSD11B2, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP12, NR1H4, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, XDH |
4.0152 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
3.99295 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, HMGCR, HSPA1A, MET, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, THRB, TNKS2 |
3.71166 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
3.68453 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.68453 |
[MF] GO:0004887 |
None
|
NR1H4, THRA, THRB |
3.68182 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS2, TYR |
3.60017 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX15, ALOX5, IDO1, PTGS2 |
3.52705 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AOX1, AURKB, AXL, CDK6, CSNK2A1, DAO, EGFR, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NR1H4, NUAK1, PIM1, SRC, TEK, XDH |
3.48081 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.47226 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX15, ALOX5, IDO1, PTGS2 |
3.47226 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, HMGCR, MET, PPARA, PTPN1, SMAD3 |
3.46394 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
3.41807 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.37219 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.37219 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.37033 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.32192 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
3.18523 |
[MF] GO:0043168 |
anion binding
|
ALOX15, AOX1, AURKB, AXL, CDK6, CSNK2A1, DAO, EGFR, F10, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NR1H4, NUAK1, PIM1, SRC, TEK, XDH |
3.18029 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, ADRA2C, AOX1, BCL2, CSNK2A1, EGFR, ESR1, ESR2, FLT3, HMGCR, IGF1R, KDR, MET, MMP9, PTGS2, SMAD3, TYR, XDH |
3.0181 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.95799 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.95799 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, AOX1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HMGCR, HSD11B2, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP12, NR1H4, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, XDH |
2.91131 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, F10, F3, FLT3, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK |
2.79703 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.75735 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.64652 |
[MF] GO:0000166 |
nucleotide binding
|
AOX1, AURKB, AXL, CDK6, CSNK2A1, DAO, EGFR, FLT3, HMGCR, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, XDH |
2.59189 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AOX1, AURKB, AXL, CDK6, CSNK2A1, DAO, EGFR, FLT3, HMGCR, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, XDH |
2.59005 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.56813 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.56813 |
[MF] GO:0004938 |
None
|
ADRA2A, ADRA2C |
2.56813 |
[MF] GO:1901338 |
None
|
ADRA2A, ADRA2C, DRD1 |
2.45853 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.33601 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.33601 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.33601 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.33601 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, DRD1, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK |
2.3247 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, DRD1, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK |
2.3247 |
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADORA1, ADRA2A, ADRA2C, AOX1, AXL, BCL2, DAO, EGFR, FLT3, HMGCR, PTGS2, SMAD3, TYR, XDH |
2.30934 |
[MF] GO:0008134 |
transcription factor binding
|
BCL2, ESR1, ESRRB, FLT3, NR1H4, PIM1, PPARA, SMAD3, SRC, THRA |
2.29995 |
[MF] GO:0019903 |
protein phosphatase binding
|
BCL2, EGFR, HMGCR, MET, PTPN1 |
2.29995 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.27074 |
[MF] GO:0017171 |
serine hydrolase activity
|
ACHE, F10, F3, MMP1, MMP12, MMP2, MMP9 |
2.23011 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.16884 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.16884 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.16884 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.14786 |
[MF] GO:0051721 |
None
|
BCL2, HMGCR, PTPN1 |
2.10727 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.07189 |
[MF] GO:0004936 |
None
|
ADRA2A, ADRA2C |
2.03468 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.03468 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.03468 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.01114 |